This enactment designates the 17th day of May in each and every year as “National Diffuse Midline Glioma Awareness Day”.

Preamble

Whereas diffuse midline glioma is an aggressive brain tumour that attacks the brainstem and slowly destroys all vital functions even as cognitive functions remain intact, rendering the affected person a prisoner in their own body;

Whereas diffuse midline glioma typically affects children who are five to seven years of age;

Whereas diffuse midline glioma remains inoperable, incurable and fatal;

Whereas the prognosis and treatments have not improved in more than 40 years;

Whereas the Parliament of Canada wishes to increase awareness of this disease among Canadians in order to encourage public and private investment in research to improve the prognosis and treatments;

Whereas it is important to honour those who have died of this disease;

And whereas the 17th day of May of each year is recognized in a number of other countries as a diffuse midline glioma awareness day;

His Majesty, by and with the advice and consent of the Senate and House of Commons of Canada, enacts as follows: